Both misunderstood and mismanaged, low back pain is a huge source of suffering for many people worldwide. Here's the up-to-date knowledge on the condition and some advice on the steps people can take ...

Flying can make some people queasy, especially when there’s unexpected turbulence. If you can choose your seat assignment ...

The following is a summary of “Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants ...

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building about a slew of additional drug targets.

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

Sinus Headaches, Sinus Infections, and Migraine Like fraternal twins, migraine attacks and sinus headaches (due to sinusitis) are often confused with each other. Frequently, people attribute sinus ...

Approximately 10 million people suffer from migraines in the UK. The condition is most common between ages 25-55, with women more likely to suffer. It’s not known what causes them and they can ...

In a small 2010 study, 12 out of 14 people with migraine did report a headache after receiving intravenous CGRP; four of them also experienced aura symptoms such as vision changes. Only two out of ...

Aug. 28, 2024 — When taken at the first signs of a migraine, before headache pain begins, a drug called ubrogepant may be effective in helping people with migraine go about their daily lives ...

A migraine episode may have up to four distinct stages or phases, each of varying duration: prodrome, aura, headache, and postdrome. But not everyone experiences all the stages all the time.